CHI3L1 and Obesity: Intriguingly, beyond the chronic inflammations delineated in Section 2.1, emerging evidence indicates the modulation of cardiovascular diseases, liver injuries, kidney diseases, systemic musculoskeletal disorders, and obesity by CHI3L1.